| 1 |
黄洁夫, 李焯辉, 郭志勇, 等. 中国器官捐献的发展历程[J]. 中华重症医学电子杂志, 2017,3(2):81-84.
|
| 2 |
刘麟炯, 元文勇, 金律, 等. 2022 年全球器官捐献概况[J/CD].实用器官移植电子杂志, 2024,12(2):153-158.
|
| 3 |
董建辉, 刘旭阳, 王洪良, 等. 《移植器官质量与安全指南( 第6版)》解读——潜在供者的识别与转介[J]. 器官移植, 2020, 11(3):395-399.
|
| 4 |
中华医学会器官移植学分会, 中国医师协会器官移植医师分会.中国公民逝世后捐献供器官功能评估和维护专家共识(2016 版)[J/CD].中华移植杂志:电子版, 2016, 10(4):145-153.
|
| 5 |
Srivastava V, Nakra M, Shankar K A, et al. Optimal management of brain-dead organ donor[J]. Med J Armed Forces India, 2020, 77(1):1-5.
|
| 6 |
Pennefather SH, Bullock RE, Dark JH. The effect of fluid therapy on alveolar arterial oxygen gradient in brain-dead organ donors[J].Transplantation, 1993,56(6):1418-1422.
|
| 7 |
Chen EP, Bittner HB, Kendall SW, et al. Hormonal and hemodynamic changes in a validated animal model of brain death[J].Crit Care Med, 1996,24(8):1352-1359.
|
| 8 |
Takada M, Nadeau KC, Hancock WW, et al. Effects of explosive brain death on cytokine activation of peripheral organs in the rat[J].Transplantation, 1998,65(12): 1533-1542.
|
| 9 |
中华医学会器官移植学分会. 尸体器官捐献供体及器官评估和维护规范(2019 版)[J]. 器官移植, 2019,10(3):253-262.
|
| 10 |
国家卫生健康委. 国家卫生健康委办公厅关于印发人体器官获取组织基本要求和质量控制指标的通知[EB/OL]. (2019-02-26)[2024-06-05]. http:/ /www. nhc. gov. cn/yzygj/pqt/201903/d75497351bf34e3698ff1836158e38d6.shtml.
|
| 11 |
中国医师协会重症医学医师分会. 重症医学科建设与管理指南(2020 版)[EB/OL]. (2021-04-01) [2024-04-05]. https:/ /www.cn-healthcare.com/articlewm/20210401/content-1205567.html.
|
| 12 |
袁海英, 唐以勇, 杨方, 等. 重症监护病房( ICU)的建设及管理探讨[J]. 四川生理科学杂志, 2014, 36(1): 24-25.
|
| 13 |
中国医师协会器官移植医师分会, 中华医学会外科学分会器官移植学组, 中国肝移植注册中心科学委员会, 等. 中国移植器官保护专家共识(2016 版)[J/CD]. 中华移植杂志: 电子版,2016,7(5):98-106.
|
| 14 |
张水军. 死亡后器官捐献供者器官的质量评估与保护[J]. 中华器官移植杂志, 2018, 39(11):643-644.
|
| 15 |
周俏华, 陈惠瑶. 基于目标导向的ICU 脑死亡供体器官功能维护策略[J]. 现代医院, 2020, 20(5):753-755.
|
| 16 |
李妍, 郭爱敏. 提高ICU 护士对使用呼吸机患者抬高床头依从性的策略和效果[J]. 中华护理杂志, 2014,49(1): 40-43.
|
| 17 |
Marklin GF, O′Sullivan C, Dhar R. Ventilation in the prone position improves oxygenation and results in more lungs being transplanted from organ donors with hypoxemia and atelectasis[J]. J Heart Lung Transplant, 2021, 40(2): 120-127.
|
| 18 |
Watanabe Y, Galasso M, Watanabe T, et al. Donor prone positioning protects lungs from injury during warm ischemia[J]. Am J Transplant, 2019,19(10): 2746-2755.
|
| 19 |
傅麒宁, 吴洲鹏, 孙文彦, 等. 《输液导管相关静脉血栓形成中国专家共识》临床实践推荐[J]. 中国普外基础与临床杂志,2020,27(4): 412-418.
|
| 20 |
亚洲急危重症协会中国腹腔重症协作组. 重症患者中心静脉导管管理中国专家共识(2022 版)[J]. 中华消化外科杂志, 2022,21(3):313-322.
|
| 21 |
Parienti JJ, Mongardon N, Bruno Mégarbane, et al. Intravascular complications of central venous catheterization by insertion site[J]. N Engl J Med, 2015,373(13):1220-1229.
|
| 22 |
Bogossian EG, Taccone FS. Fever management in acute brain injury[J]. Curr Opin Crit Care, 2022,28(2):130-137.
|
| 23 |
Mrozek S, Vardon F, Geeraerts T. Brain temperature: physiology and pathophysiology after brain injury[J]. Anesthesiol Res Pract,2012:989487.
|
| 24 |
Koenig MA, Kaplan PW. Brain death[J]. Handb Clin Neurol,2019,161(1): 89-102.
|
| 25 |
Morrison LJ, Thoma B. Translating targeted temperature management trials into postarrest care[J]. N Engl J Med, 2021,384(24):2344-2345.
|
| 26 |
Niemann CU, Feiner J, Swain S, et al. Therapeutic hypothermia in deceased organ donors and kidney-graft function[J]. N Engl J Med,2015,373(5):405-414.
|
| 27 |
Schnuelle P, Mundt HM, Drüschler F, et al. Impact of spontaneous donor hypothermia on graft outcomes after kidney transplantation[J].Am J Transplant, 2018,18(3):704-714.
|
| 28 |
Hahnenkamp K, Böhler K, Wolters H, et al. Organ-protective intensive care in organ donors[J]. Dtsch Arztebl Int, 2016,113(33-34):552-558.
|
| 29 |
Westphal GA, Robinson CC, Cavalcanti AB, et al. Brazilian guidelines for the management of brain-dead potential organ donors.The task force of the AMIB, ABTO, BRICNet, and the General Coordination of the National Transplant System[J]. Ann Intensive Care, 2020,10(1):169.
|
| 30 |
Meyfroidt G, Gunst J, Martin-Loeches I, et al. Management of the brain-dead donor in the ICU: general and specific therapy to improve transplantable organ quality[J]. Intensive Care Med, 2019,45(3):343-353.
|
| 31 |
Patel MS, Salcedo-Betancourt JD, Saunders C, et al. Therapeutic hypothermia in low-risk nonpumped brain-dead kidney donors: a randomized clinical trial[J]. JAMA Netw Open, 2024,7(2):e2353785.
|
| 32 |
中国医师协会急诊医师分会, 中国医药教育协会急诊医学专业委员会, 成人急危重症脑损伤患者目标温度管理临床实践专家共识组. 成人急危重症脑损伤患者目标温度管理临床实践专家共识[J]. 中华急诊医学杂志, 2019, 28(3): 282-291.
|
| 33 |
国家卫生健康委员会脑损伤质控评价中心, 中华医学会神经病学分会神经重症协作组, 中国医师协会神经内科医师分会神经重症专业委员会. 脑死亡判定实施与管理:专家指导意见(2021)[J]. 中华医学杂志, 2021, 101(23):1766-1771.
|
| 34 |
Maki DG, Ringer M, Alvarado CJ. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters[J].Lancet, 1991, 338(8763):339-343.
|
| 35 |
Mimoz O, Lucet JC, Kerforne T, et al. Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, with and without skin scrubbing, for prevention of intravascular-catheterrelated infection (CLEAN): an open-label, multicentre, randomised,controlled, two-by-two factorial trial[J]. Lancet, 2015,386(10008):2069-2077.
|
| 36 |
Pages J, Hazera P, Mégarbane B, et al. Comparison of alcoholic chlorhexidine and povidone-iodine cutaneous antiseptics for the prevention of central venous catheter-related infection: a cohort and quasi-experimental multicenter study [J]. Intensive Care Med,2016, 42(9):1418-1426.
|
| 37 |
Yasuda H, Sanui M, Abe T, et al. Comparison of the efficacy of three topical antiseptic solutions for the prevention of catheter colonization: a multicenter randomized controlled study[J]. Crit Care, 2017, 21(1):320.
|
| 38 |
洪涵涵, 彭飞. 中央导管相关血流感染防控最佳护理实践——《导管相关感染防控最佳护理实践专家共识》系列解读之二[J].上海护理, 2019, 19 (12): 1-5.
|
| 39 |
王文琴, 闫萍, 廖云. 急诊重症监护室危重患者护理技术安全措施的探讨[J]. 重庆医学, 2015, 44(16):2298-2300.
|
| 40 |
Cohen DL, Roffe C, Beavan J, et al. Post-stroke dysphagia: a review and design considerations for future trials[J]. Int J Stroke,2016,11(4):399-411.
|
| 41 |
米元元, 黄海燕, 尚游, 等. 中国危重症患者肠内营养治疗常见并发症预防管理专家共识(2021 版)[J]. 中华危重病急救医学,2021,33(8): 903-918.
|
| 42 |
中华医学会器官移植学分会, 中华预防医学会医院感染控制学分会, 复旦大学华山医院抗生素研究所. 中国实体器官移植供者来源感染防控专家共识(2018 版)[J]. 中华器官移植杂志,2018,39(1):41-52.
|
| 43 |
Cucchiari D, Rovira J, Paredes D, et al. Association of brain-dead donors′ terminal inflammation with delayed graft function in kidney transplant recipients[J]. Transplant Proc, 2017,49(10):2260-2264.
|
| 44 |
Chiu CY, Miller SA. Clinical metagenomics[J]. Nat Rev Genet,2019,20(6):341-355.
|
| 45 |
Mille RR, Montoya V, Gardy JL, et al. Metagenomics for pathogen detection in public health[J]. Genome Med, 2013,5(9):81.
|
| 46 |
李星. 集束化护理预防机械通气伴瞬目受损重症患者暴露性角膜病变的研究[D]. 广州:南方医科大学, 2015.
|
| 47 |
周志刚, 李超, 李立, 等. 2 例脑死亡无偿器官捐献供体的维护体会[J]. 中国普外基础与临床杂志, 2012, 19(5):486-489
|
| 48 |
Pandit RA, Zirpe KG, Gurav SK, et al. Management of potential organ donor: Indian Society of Critical Care Medicine: Position Statement[J]. Indian J Crit Care Med, 2017;21(5):303-316.
|
| 49 |
Frenette AJ, Williamson DR, Weiss MJ, et al. Worldwide management of donors after neurological death: a systematic review and narrative synthesis of guidelines[J]. Can J Anaesth, 2020, 67(12): 1839-1857.
|
| 50 |
Lazzeri C, Bonizzoli M, Guetti C, et al. Hemodynamic management in brain dead donors[J]. World J Transplant, 2021,11(10):410-420.
|
| 51 |
European Committee on Organ Transplantation. 移植器官质量与安全指南. 张雷主译[M]. 北京: 科学出版社, 2019:55.
|
| 52 |
Dupuis S, Amiel JA, Desgroseilliers M, et al. Corticosteroids in the management of braindead potential organ donors: a systematic review[J]. Br J Anaesth, 2014,113(3):346-359.
|
| 53 |
Pinsard M, Ragot S, Mertes PM, et al. Interest of low-dose hydrocortisone therapy during brain-dead organ donor resuscitation:the CORTICOME study[J]. Crit care, 2014,18(4):R158.
|
| 54 |
Abdelnour T, Rieke S. Relationship of hormonal resuscitation therapy and central venous pressure on increasing organs for transplant[J]. J Heart Lung Transplant, 2009, 28(5):480-485.
|
| 55 |
Miñambres E, Ballesteros MA, Rodrigo E, et al. Aggressive lung donor management increases graft procurement without increasing renal graft loss after transplantation[J]. Clin Transpl, 2013,27(1):52-59.
|
| 56 |
Miñambres E, Pérez-Villares JM, Terceros-Almanza L, et al. An intensive lung donor treatment protocol does not have negative influence on other grafts: a multicentre study[J]. Eur J Cardiothorac Surg, 2016,49(6):1719-1724.
|
| 57 |
Powner DJ. Factors during donor care that may affect liver transplantation outcome[J]. Prog Transpl, 2004,14(3):241-247.
|
| 58 |
O′Connor KJ, Wood KE, Lord K. Intensive management of organ donors to maximize transplantation[J]. Crit Care Nurse, 2006, 26(2):94-100.
|
| 59 |
Sally MB, Ellis MK, Hutchens M, et al. Deceased organ donor factors influencing pancreatic graft transplantation and survival[J].Clin Transplant, 2019, 33(6): e13571.
|
| 60 |
Zheng D, Liu G, Chen L, et al. Effects of terlipressin on management of hypotensive brain-dead patients who are potential organ donors: a retrospective study[J]. Front Pharmacol, 2021, 12:716759.
|
| 61 |
Gruenberger T, Steininger R, Sautner T, et al. Influence of donor criteria on postoperative graft function after orthotopic liver transplantation[J]. Transpl Int, 1994, 7(S1):672-674.
|
| 62 |
delaTorre AN, Kuo PC, Plotkin JS, et al. Influence of donor base deficit status on recipient outcomes in liver transplantation[J].Transplant Proc, 1997, 29(1-2):474.
|
| 63 |
Westphal GA, Coll E, de Souza RL, et al. Positive impact of a clinical goal-directed protocol on reducing cardiac arrests during potential brain-dead donor maintenance[J]. Crit Care, 2016, 20(1):323.
|
| 64 |
Mascia L, Pasero D, Slutsky AS, et al. Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation[J]. JAMA, 2010,304(23):2620-2627.
|
| 65 |
杨顺良, 谭建明. 潜在脑死亡捐献者的器官维护[J]. 器官移植,2015, 6(5):288-293.
|
| 66 |
中华医学会神经外科学分会, 中国神经外科重症管理协作组.中国神经外科重症患者气道管理专家共识(2016)[J]. 中华医学杂志, 2016, 96(21) : 1639-1642.
|
| 67 |
中华医学会呼吸病学分会感染学组. 中国成人医院获得性肺炎与呼吸机相关性肺炎诊断和治疗指南(2018 年版)[J]. 中华结核和呼吸杂志, 2018,41(4):255-280.
|
| 68 |
李丹, 罗雅丹, 董力. 脑死亡无偿器官捐献供体维护期的护理[J]. 当代护士:中旬刊, 2015, (4) :20-21.
|
| 69 |
Apostolakis E, Parissis H, Dougenis D. Brain death and donor heart dysfunction: implications in cardiac transplantation[J]. J Card Surg,2010, 25(1):98-106.
|
| 70 |
龚丽明, 李立, 冉江华, 等. 纤支镜肺泡灌洗在脑死亡边缘性供肺维护中的作用[J]. 昆明医科大学学报, 2022,43(1): 89-95.
|
| 71 |
彭桂林, 徐鑫, 黄丹霞, 等. 62 例器官捐献供肺的评估及维护经验总结[J]. 中华外科杂志, 2016, 54(12):898-901.
|
| 72 |
Angel LF, Levine DJ, Restrepo MI, et al. Impact of a lung transplantation donor-management protocol on lung donation and recipient outcomes[J]. Am J Respir Crit Care Med, 2006, 174(6):710-716.
|
| 73 |
Powner DJ, Kellum JA. Maintaining acid-base balance in organ donors[J]. Prog Transplant, 2000, 10(2):98-103.
|
| 74 |
Totsuka E, Dodson F, Urakami A, et al. Influence of high donor serum sodium levels on early postoperative graft function in human liver transplantation: effect of correction of donor hypernatremia[J].Liver Transpl Surg, 1999,5(5):421-428.
|
| 75 |
Cacciatori A, Godino M, Mizraji R. Addressing a diagnosis of brain death in hypernatremia situation[J]. Transplant Proc, 2020, 52(4):1056-1061.
|
| 76 |
Kuhn SO, Hahnenkamp K, et al. Critical care management of the potential organ donor : current recommendation for adults[J]. Med Klin Intensivmed Notfmed, 2019,114(2):132-138.
|
| 77 |
Salim A, Martin M, Brown C, et al. Complications of brain death:frequency and impact on organ retrieval[J]. Am Surg, 2006, 72(5):377-381.
|
| 78 |
Sally MB, Ewing T, Crutchfield M, et al. Determining optimal threshold for glucose control in organ donors after neurologic determination of death: a United Network for Organ Sharing Region 5 Donor Management Goals Workgroup prospective analysis[J]. J Trauma Acute Care Surg, 2014, 76(1):62-68.
|
| 79 |
NICE-SUGAR Study Investigators; Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients[J]. N Engl J Med, 2009, 360(1):1283-1297.
|
| 80 |
Perez-Protto SE, Reynolds LF, Dalton JE, et al. Deceased donor hyperglycemia and liver graft dysfunction [J]. Prog Transplant,2014,24(1):106-112.
|
| 81 |
窦晓婧, 王清平, 张玮晔, 等. 胰岛素强化血糖管理对器官捐献者循环及心功能的影响[J]. 中华器官移植杂志, 2022, 43(3):156-160.
|
| 82 |
Gores PF, Gillingham KJ, Dunn DL, et al. Donor hyperglycemia as a minor risk factor and immunologic variables as major risk factors for pancreas allograft loss in a multivariate analysis of a single institution′s experience[J]. Ann Surg, 1992, 215(3):217-230.
|
| 83 |
Novitzky D, Cooper DK, Reichart B. Hemodynamic and metabolic responses to hormonal therapy in brain-dead potential organ donors[J]. Transplantation, 1987,43(6):852-854.
|
| 84 |
Phongsamran PV. Critical care pharmacy in donor management[J].Prog Transplant. 2004,14(2):105-111.
|
| 85 |
Zaroff JG, Rosengard BR, Armstrong WF, et al. Consensus conference report: maximizing use of organs recovered from the cadaver donor: cardiac recommendations, March 28-29, 2001,Crystal City, Va[J]. Circulation, 2002, 106(7): 836-841.
|
| 86 |
Rosendale JD, Kauffman HM, McBride MA, et al. Aggressive pharmacologic donor management results in more transplanted organs[J]. Transplantation, 2003,75(4): 482-487.
|
| 87 |
Finfer S, Bohn D, Colpitts D, et al. Intensive care management of paediatric organ donors and its effect on post -transplant organ function[J]. Intensive Care Med, 1996, 22(12):1424-1432.
|
| 88 |
Blasco V, Leone M, Bouvenot J, et al. Impact of intensive care on renal function before graft harvest: results of a monocentric study[J].CritCare, 2007, 11(5):R103.
|
| 89 |
Shen GK, Recicar JF, Hovsepian RV, et al. Correction of base deficits in deceased organ donors: effects on immediate renal allograft function[J]. Transplant Proc, 2004, 36(9) : 2559-2561.
|
| 90 |
Irish GL, Coates PT, Clayton PA. Association of admission, nadir,and terminal donor creatinine with kidney transplantation outcomes[J]. Kidney Int Rep, 2021,6(8):2075-2083.
|
| 91 |
Scurt FG, Ernst A, Hammoud B, et al. Effect of creatinine metrics on outcome after transplantation of marginal donor kidneys[J].Nephrology (Carlton), 2022,27(12): 973-982.
|
| 92 |
中华医学会神经外科学分会, 中国神经外科重症管理协作组.中国神经外科重症患者消化与营养管理专家共识(2016)[J].中华医学杂志, 2016, 96(21):1643-1647.
|
| 93 |
Schirmer CM, Kornbluth J, Heilman CB, et al. Gastrointestinal prophylaxis in neurocritical care[J]. Neurocrit Care, 2012, 16(1):184-193.
|
| 94 |
Lasky MR, Metzler MH, Phillips JO. A prospective study of omeprazole suspension to prevent clinically significant gastrointestinal bleeding from stress ulcers in mechanically ventilated trauma patients[J]. J Trauma, 1998, 44(3):527-533.
|
| 95 |
中国神经外科医师协会神经创伤专家委员会, 中华医学会创伤学分会神经创伤专业学组.神经外科危重昏迷患者肠内营养专家共识[J]. 中华创伤杂志, 2010, 26(12): 1057-1059.
|
| 96 |
中华医学会. 临床诊疗指南:肠外肠内营养学分册(2008 版)[M]. 北京:人民卫生出版社, 2008: 12.
|
| 97 |
Dominguez-Roldan JM, Murillo-Cabezas F, Santamaria-Mifsut JL, et al. Changes in resting energy expenditure after development of brain death[J]. Transplant Proc, 1995, 27(4):2397-2398.
|
| 98 |
Foley N, Marshall S, Pikul J, et al. Hypermetabolism following moderate to severe traumatic acute brain injury: a systematic review[J]. J Neurotrauma, 2008, 25(12):1415-1431.
|
| 99 |
Mccall M, Jeejeebhoy K, Pencharz P, et al. Effect of neuromuscular blockade on energy expenditure in patients with severe head injury[J]. JPEN J Parenter Enteral Nutr, 2003, 27(1):27- 35.
|
| 100 |
中华医学会重症医学分会. 中国重症加强治疗病房危重患者营养支持指导意见(2006)[J]. 中华外科杂志, 2006, 44(17):1167-1177.
|
| 101 |
Kotloff RM, Blosser S, Fulda GJ, et al. Management of the potential organ donor in the ICU: Society of Critical Care Medicine/American College of Chest Physicians/Association of Organ Procurement Organizations Consensus Statement [J]. Crit Care Med, 2015, 43(6):1291-1325.
|
| 102 |
Westphal GA, Caldeira Filho M, Vieira KD, et al. Guidelines for potential multiple organ donors (adult): part Ⅱ. Mechanical ventilation, endocrine metabolic management, hematological and infectious aspects[J]. Rev Bras Ter Intensiva, 2011, 23(3):269-282.
|
| 103 |
Schünemann HJ, Moja L. Reviews: Rapid! Rapid! Rapid! …and systematic[J]. Syste Rev, 2015, 4(1):4.
|
| 104 |
Shemie SD. Organ donor management in Canada: recommendations of the forum on Medical Management to Optimize Donor Organ Potential[J].CMAJ, 2006,174(6):S13-S32.
|
| 105 |
Singer P, Cohen J, Cynober L. Effect of nutritional state of braindead organ donor on transplantation[J]. Nutrition, 2001,17(11-12):948-952.
|
| 106 |
Javadov SA, Lim KH, Kerr PM, et al. Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition[J]. Cardiovasc Res, 2000,45(2):360-369.
|
| 107 |
Marklin GF, Ewald L, Klinkenberg WD, et al. The benefits of initiating continuous renal replacement therapy after brain death in organ donors with oligoanuric acute kidney injury [ J]. Clin Transplant, 2022, 36(9): e14764.
|
| 108 |
Dhanani S, Shemie SD. Advancing the science of organ donor management[J]. Crit Care, 2014, 18(6):612.
|
| 109 |
雷志影, 黄丽娜, 毛海艳, 等. 全程风险管理联合连续性血液净化在肾脏捐献供体者功能维护中的应用[J]. 齐鲁护理杂志,2021, 27(11):19-22.
|
| 110 |
黄健, 尹攀, 岳冰清, 等. 连续性肾脏替代治疗在肺移植边缘性供肺维护中的临床价值[J]. 临床外科杂志, 2022,30(10):994-997.
|
| 111 |
国家卫生健康委员会. 血液净化标准操作规程(2021 版)[Z].2021-11-09.
|
| 112 |
何重香, 余红梅, 李宁, 等. 体外膜肺氧合在公民逝世后器官捐献中的应用流程与维护[J]. 武汉大学学报:医学版, 2016,37(4):565-567.
|
| 113 |
李维, 罗雅丹, 王翩翩, 等. 中国一类捐献供体应用体外膜肺氧合技术的配合与监护[J]. 当代护士:中旬刊, 2017(2):107-108.
|
| 114 |
中华医学会器官移植学分会, 中国医师协会器官移植医师分会. 体外膜肺氧合在中国公民逝世后捐献供器官保护中的应用专家共识(2016 版)[J/CD]. 中华移植杂志: 电子版, 2016, 10(3): 107-111.
|
| 115 |
国家人体捐献器官获取质量控制中心, 中华医学会急诊医学分会体外生命支持学组, 中国医院协会器官获取与分配工作委员会. 体外膜肺氧合辅助潜在捐献者院际转运专家共识[J]. 中国急救医学, 2023, 43(8):589-596.
|
| 116 |
余文静, 高兴莲, 吴佳颖, 等. 脑死亡器官捐献患者供心获取的护理配合[J]. 护理学报, 2014, 21(3):65-67.
|
| 117 |
Vijayalakshmi P, Nagarajaiah, Ramachandra, et al. Indian ICU nurses′ perceptions of and attitudes towards organ donation[J]. Br J Nurs, 2015,24(13):694-697.
|
| 118 |
江文诗, 孙永康, 闫娟, 等. 2020 年全球器官捐献和移植概况[J]. 器官移植, 2021,12(4):376-383.
|
| 119 |
中国人体健康科技促进会人体器官和组织捐献专业委员会. 器官捐献: 我国新时代下多学科共创的新生学科[J]. 器官移植,2020,11(5):614-621.
|
| 120 |
江文诗, Gomez MP, Paez G, 等. 数据之美——聚焦全球器官捐献发展趋势[J/CD]. 中华移植杂志: 电子版, 2019, 13(1):28-33.
|
| 121 |
江文诗. 站在亚洲看世界: 亚洲视角下脑死亡器官捐献的可持续健康发展[J]. 器官移植, 2022, 13(6):697-710.
|